NEWS AND PRESS
News room
March 25, 2010 | media: Press Release
Disitertide (P144), jointly developed by ISDIN and Digna Biotech showed a statistically significant improvement versus placebo in the patients that perceived improvement of the treated skin area affected by systemic sclerosis
News room
January 19, 2010
Digna Biotech starts the clinical research phase with interferon alpha-5 in patients with genotype 1 chronic hepatitis C that have not healed with previous treatment
News room
May 15, 2009 | media: Press Release
Cardiotrophin-1 showed to improve survival in a rabbit model of fulminant hepatic failure (FHF) of viral origin.
News room
July 28, 2008
Biotecnol and Digna Biotech extend their existing collaboration on the development of Cardiotrophin-1 through an exclusive marketing, promotion and option agreement
News room
May 8, 2008
Digna Biotech and Aachen Resonance signed an agreement for the joint development of drug eluting devices.
News room
October 23, 2007
Digna Biotech obtains the financial support of Clave Mayor and Suan Farma Biotech for the clinical development of the Cardiotrophine-1
© Digna Biotech · Legal Information
Top